Understanding how the outer layer of a drug-resistant bacteria works
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
This study is looking at a tough bacteria called Acinetobacter baumannii to understand how its protective outer layer works, with the hope of finding new ways to help patients who struggle with antibiotic-resistant infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-11045865 on NIH RePORTER |
What this research studies
This research investigates the outer membrane of Acinetobacter baumannii, a bacteria known for its resistance to multiple antibiotics. By examining how this membrane maintains its structure and function, the research aims to uncover new strategies for combating antibiotic resistance. The approach involves studying the unique characteristics of the membrane and how it protects the bacteria from treatments. Patients may benefit from new therapies developed as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by Acinetobacter baumannii or other multi-drug resistant pathogens.
Not a fit: Patients with infections caused by bacteria that are not resistant to antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research has shown promise in targeting the unique properties of bacterial membranes to combat antibiotic resistance, indicating that this approach could be effective.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Trent, Michael Stephen — University of Georgia
- Study coordinator: Trent, Michael Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.